Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2001 Nov;51(472):879–883.

The predictive value of asthma medications to identify individuals with asthma--a study in German general practices.

W Himmel 1, E Hummers-Pradier 1, H Schümann 1, M M Kochen 1
PMCID: PMC1314143  PMID: 11761200

Abstract

BACKGROUND: The assessment of prescribing performance by aggregated measures mainly developed from automated databases is often helpful for general practitioners. For asthma treatment, the frequently applied ratio of anti-inflammatory to bronchodilator drugs may, however, be misleading if the specificity of a drug for the treatment of asthma, compared with other diseases, is unknown. AIM: To test the association of specific drugs with the diagnosis of asthma compared with other diagnoses. DESIGN OF STUDY: Cross-sectional study analysing prescription data from a retrospective chart review. SETTING: Eight general practices and one community respiratory practice in a town in Northern Germany. METHOD: All patients in the participating practices who received at least one of the 50 asthma drugs most frequently prescribed in Germany within the past 12 weeks were identified. Odds ratios (ORs) with 95% confidence intervals (ClI) were calculated to reveal any association between a specific drug and the diagnosis of asthma. The unit of analysis was the item prescribed. RESULTS: Topical betamimetics (e.g salbutamol, fenoterol) were the most often prescribed asthma drugs in the general practices (52.1 ) and in the respiratory practice (57.6%). Inhaled steroids accounted for 15% and 13%; systemic steroids accounted for 10% and 13%, respectively. In the general practices, inhaled betamimetics had a moderate marker function for asthma (OR = 2.0; 95% CI = 1.14-3.58). A fixed oral combination drug of clenbuterol plus ambroxol was a marker drug against asthma (OR = 0.35; 95% CI = 0.20-0.61). In the respiratory practice, the diagnosis of asthma was strongly marked by fixed combinations of cromoglycate plus betamimetics (OR = 29.0; 95% CI = 6.86-122.24) and moderately by inhaled betamimetics (OR = 2.6; 95% CI = 1.28-5.14). In contrast, systemic steroids (OR = 0.24; 95% CI 0.10-0.57) and even inhaled steroids (OR = 0.46; 95% ClI= 0.22-0.96) proved to contradict the diagnosis of asthma. CONCLUSION: Only betamimetics were markers for asthma patients in both types of practices; inhaled steroids, however, were not. Combinations of cromoglycate were markers in the respiratory practice only. Limited specificity of drugs for a disease (e.g asthma) should be taken into account when analysing prescribing data that are not diagnosis linked.

Full Text

The Full Text of this article is available as a PDF (79.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman D. N., Eccles M., Campbell M., Soutter J., Roberts S. J., Smith J. M. Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Pract. 1996 Jan;46(402):20–25. [PMC free article] [PubMed] [Google Scholar]
  2. Bousquet J., Chanez P., Vignola A. M., Michel F. B. Asthma and chronic bronchitis: similarities and differences. Respir Med. 1996 Apr;90(4):187–190. doi: 10.1016/s0954-6111(96)90285-1. [DOI] [PubMed] [Google Scholar]
  3. Burge P. S., Calverley P. M., Jones P. W., Spencer S., Anderson J. A., Maslen T. K. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000 May 13;320(7245):1297–1303. doi: 10.1136/bmj.320.7245.1297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cabana M. D., Rand C. S., Powe N. R., Wu A. W., Wilson M. H., Abboud P. A., Rubin H. R. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999 Oct 20;282(15):1458–1465. doi: 10.1001/jama.282.15.1458. [DOI] [PubMed] [Google Scholar]
  5. Fabbri L., Caramori G., Beghe B., Papi A., Ciaccia A. Chronic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med. 1998 Mar;4(2):76–84. doi: 10.1097/00063198-199803000-00004. [DOI] [PubMed] [Google Scholar]
  6. Frischer M., Heatlie H., Chapman S., Norwood J., Bashford J., Millson D. Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker? Public Health. 1999 Sep;113(5):247–250. doi: 10.1038/sj.ph.1900583. [DOI] [PubMed] [Google Scholar]
  7. García Rodríguez L. A., Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998 May;45(5):419–425. doi: 10.1046/j.1365-2125.1998.00701.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hummers-Pradier E., Hinrichs I., Schroeter M., Kochen M. M. Asthma bronchiale--Vorstellungen und Konzepte von Hausärzten. Z Arztl Fortbild Qualitatssich. 2000 Jun;94(5):379–387. [PubMed] [Google Scholar]
  9. Jackevicius C. A., Chapman K. R. Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: a survey. Ann Pharmacother. 1997 Feb;31(2):160–164. doi: 10.1177/106002809703100204. [DOI] [PubMed] [Google Scholar]
  10. Keeley D. How to achieve better outcome in treatment of asthma in general practice. BMJ. 1993 Nov 13;307(6914):1261–1263. doi: 10.1136/bmj.307.6914.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lagerløv P., Veninga C. C., Muskova M., Hummers-Pradier E., Stålsby Lundborg C., Andrew M., Haaijer-Ruskamp F. M. Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. Eur Respir J. 2000 Jan;15(1):25–29. [PubMed] [Google Scholar]
  12. Legorreta A. P., Christian-Herman J., O'Connor R. D., Hasan M. M., Evans R., Leung K. M. Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience. Arch Intern Med. 1998 Mar 9;158(5):457–464. doi: 10.1001/archinte.158.5.457. [DOI] [PubMed] [Google Scholar]
  13. Marklund B., Tunsäter A., Bengtsson C. How often is the diagnosis bronchial asthma correct? Fam Pract. 1999 Apr;16(2):112–116. doi: 10.1093/fampra/16.2.112. [DOI] [PubMed] [Google Scholar]
  15. Roghmann M. C., Sexton M. Adherence to asthma guidelines in general practices. J Asthma. 1999 Jun;36(4):381–387. doi: 10.3109/02770909909068231. [DOI] [PubMed] [Google Scholar]
  16. Shelley M., Croft P., Chapman S., Pantin C. Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity? J Clin Epidemiol. 2000 Dec;53(12):1217–1221. doi: 10.1016/s0895-4356(00)00249-3. [DOI] [PubMed] [Google Scholar]
  17. Veninga C. C., Denig P., Pont L. G., Haaijer-Ruskamp F. M. Comparison of indicators assessing the quality of drug prescribing for asthma. Health Serv Res. 2001 Apr;36(1 Pt 1):143–161. [PMC free article] [PubMed] [Google Scholar]
  18. Veninga C. C., Lagerløv P., Wahlström R., Muskova M., Denig P., Berkhof J., Kochen M. M., Haaijer-Ruskamp F. M. Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Project Group. Am J Respir Crit Care Med. 1999 Oct;160(4):1254–1262. doi: 10.1164/ajrccm.160.4.9812136. [DOI] [PubMed] [Google Scholar]
  19. Vollmer W. M., O'Hollaren M., Ettinger K. M., Stibolt T., Wilkins J., Buist A. S., Linton K. L., Osborne M. L. Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med. 1997 Jun 9;157(11):1201–1208. [PubMed] [Google Scholar]
  20. Wettengel R., Berdel D., Hofmann D., Krause J., Kroegel C., Kroidl R. F., Leupold W., Lindemann H., Magnussen H., Meister R. Asthmatherapie bei Kindern und Erwachsenen. Empfehlungen der Deutschen Atemwegsliga in der Deutschen Gesellschaft für Pneumologie. Med Klin (Munich) 1998 Nov 15;93(11):639–650. doi: 10.1007/BF03044875. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES